Skip to main content
Caplight Logo









Novus Scientific

Novus Scientific

Private
UppsalaHealthcare & Life Scienceshttps://tigrmatrix.com/

Last Round

Grant

Jan 1, 2017

Total Funding Raised

$830,800

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Novus Scientific is a medical technology company that develops, manufactures, and markets TIGR Matrix, a long-term resorbable synthetic surgical mesh for soft tissue reinforcement.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

surgical meshresorbable meshhernia repairbreast reconstructionsoft tissue reinforcementsynthetic meshbiomaterialsmedtechabdominal wall reconstructionmedical devicesabsorbable implantsurgical implantplastic surgeryreconstructive surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novus Scientific Comparables

Compare Novus Scientific with similar companies based on industry and business-model similarity.

Novus Scientific comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neomend
85%
TELA Bio, Inc.
81%
Deep Blue Medical Advances
81%

Novus Scientific Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2017
GrantAug 28, 2016

Key People

Founding team and executive leadership

Henrik Magnusson Hjorth

CEO

Executive Team

Novus Scientific Investors

Notable investors and investment history

Novus Scientific investors
InvestorRounds
The University of Hong KongGrant
Hong Kong Science and Technology Parks CorporationAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors increased 47% MoM.

  • May 25, 2026

    Grew 20% QoQ, from 15 to 18 employees.

Novus Scientific Filings

Explore SEC and related filing metadata, where available.

Novus Scientific filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Novus Scientific's valuation, stock price, and market status.

Is Novus Scientific a public or private company?

Novus Scientific is a private company.

What is the current stock price of Novus Scientific?

Novus Scientific is a private company with no public stock price. Caplight tracks Novus Scientific's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Novus Scientific worth (valuation)?

Valuation information for Novus Scientific is not publicly available.

Can I buy Novus Scientific stock?

Novus Scientific shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Novus Scientific's last funding round?

Novus Scientific's most recent funding round was Grant on January 1, 2017.

Who are the main investors in Novus Scientific?

Key investors in Novus Scientific include Hong Kong Science and Technology Park.

Will Novus Scientific IPO soon?

No public IPO plans have been announced for Novus Scientific.

How can I track Novus Scientific secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novus Scientific's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUppsala
Employee Range12
Year Founded2008
Last FundingJan 1, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?